Table 2.
Odds of gestational diabetes (GDM) according to HbA1c level at 8–13 weeks and the change in HbA1c from 8–13 weeks and 16–22 and 24–29 weeks, NICHD Fetal Growth Studies- Singletons (2009–2013).
Crude Modelb | Adjusted Modelb,c | |||
---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | |
HbA1c at Visit 0a | ||||
Per 0.1% | 1.27 (1.14, 1.40) | <0.001 | 1.22 (1.09, 1.36) | <0.001 |
Change in HbA1c from visit 0 to 1a | ||||
Per 0.1% | 1.10 (0.95, 1.16) | 0.19 | 1.04 (0.90, 1.21) | 0.57 |
Change in HbA1c from visit 0 to 2a | ||||
Per 0.1% | 1.21 (1.01, 1.44) | 0.03 | 1.21 (1.01, 1.45) | 0.04 |
Abbreviations: CI, confidence interval.
aVisit 0: 8–13 weeks. Visit 1: 16–22 weeks. Visit 2: 24–29 weeks.
bNon-GDM controls matched to each GDM case on maternal age (±2 years), race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, Asian/Pacific Islander), and gestational week of blood collection (±2 weeks). Models additional adjusted for maternal age and gestational age at delivery to remove any remaining residual confounding with these factors.
cModel additionally adjusted for family history of diabetes and pre-pregnancy overweight and obesity.